Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. Commercialization of non-invasive cancer diagnosis is possible due to completion of Human Genome Project (HGP) that gives enormous diagnostic information based on genomic and proteomic. Increase in stringent regulatory guidelines and cost associated with diagnostics is hindering the growth of non-invasive cancer diagnostic market. The Ovarian Cancer National Alliance regulations for monitoring non-invasive diagnostics are issued by FDA, Medicare and Medicaid Services (CMS) and Social Security Administration (SSA).
The global non-invasive market has a huge potential in developing countries; however, cost of diagnosis is creating hurdles to tap this market. Hence, to overcome this problem, the diagnostic market has to be analyzed by the developing countries such as China, Japan, and India. This report provides key market drivers that are driving the market with impact analysis. The report gives intelligence about key regulatory guidelines issued by respective governments.
Key companies included in report are Precision Therapeutics, A&G Pharmaceutical, Affymetrix Inc., AVIVA Biosciences Corporation, BIOVIEW Inc., Laboratory Corporation of America Holdings (LabCorp), , Quest Diagnostics Incorporated Cancer Genetics Inc., Digene Corporation, Gen-Probe Incorporated,
KEY MARKET SEGMENTS
GLOBAL MARKET, BY THERAPEUTICS
• Solid tumors
• Blood cancer
• Lung Cancer
• Breast Cancer
GLOBAL MARKET, BY TECHNIQUES
• Clinical Chemistry
• Molecular Diagnostics
• Other Clinical Instruments
GLOBAL MARKET, BY GEOGRAPHY
• North America
• Medical devices manufacturing companies
• Pharmaceutical companies
• Government and Private Research Institutes
• Academic Institutes
SIMILAR MARKET STUDIES
Notes: Production, means the output of Medical Imaging Information System Revenue, means the sales value of Medical Imaging Information System This report studies Medical Imaging Information System in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and ...
November 2016 | $2900 | View Details >>
Summary Mochida Pharmaceutical Co., Ltd. (Mochida) is a healthcare company. The company contributes in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. Its products include Epadel, Atelec, Atedio, Rocornal, Beselna Cream, Florid, Miraclid, Thrombin Mochida, Uronase, Cand-Tec, Fastic, Tecipul, Grandaxin, among others. Mochida’s business activities ...
October 2014 | $300 | View Details >>
The United States Wax Heaters and Scalding Units Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Wax Heaters and Scalding Units industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Wax Heaters ...
March 2016 | $3800 | View Details >>
Notes: Sales, means the sales volume of Subdural Strip Electrode Revenue, means the sales value of Subdural Strip Electrode This report studies Subdural Strip Electrode in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Ad-Tech Medical DIXI MEDICAL Intamed ...
March 2017 | $3200 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research